STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
InvestmentMay 6, 2026, 08:32 AM

InflaRx Prices $150M Underwritten Offering of 75M Ordinary Shares

AI Summary

InflaRx N.V. announced the pricing of an underwritten offering of 75,000,000 ordinary shares at $2.00 per share, totaling $150,000,000 in gross proceeds. The offering, expected to close on May 7, 2026, includes participation from new and existing investors such as TCGX and Farallon Capital Management. The company intends to use the net proceeds to advance its pipeline activities, for working capital, and general corporate purposes.

Key Highlights

  • InflaRx priced an underwritten offering of 75,000,000 ordinary shares.
  • The offering price is $2.00 per ordinary share.
  • The total gross proceeds from the offering are $150,000,000.
  • The offering is expected to close on May 7, 2026.
  • Net proceeds will be used to advance pipeline activities, for working capital, and general corporate purposes.
  • New and existing investors, including TCGX and Farallon Capital Management, participated.
IFRX
Biotechnology: Pharmaceutical Preparations
InflaRx N.V.

Price Impact